Conceptio › Archive › HAL (France)
HAL (France)open access

First-Line LV5FU2 with or without Aflibercept in Patients with Non-Resectable Metastatic Colorectal Cancer: A Randomized Phase II Trial (PRODIGE 25-FFCD-FOLFA)

Jean-Louis Legoux et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
0, 1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 326103
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.